MedTrace Logo

Database Retrieval for the Comprehensive Shoulder

NCT03409718 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2025-10-30

No results posted yet for this study

Summary

This study is a retrieval of database information regarding survivorship of the Comprehensive Shoulder System family of products. The primary objective of the retrieval is to collect data that will contribute to the post market surveillance requirements for this product and will provide feedback to design engineers, support marketing efforts and publications, and answer potential questions form reimbursement agencies.

Conditions

  • Osteoarthritis of the Shoulder
  • Avascular Necrosis
  • Rheumatoid Arthritis
  • Prior Failed Revision
  • Correction of Functional Deformity
  • Fracture of Proximal End of Humerus
  • Cuff Tear Arthropathy

Interventions

DEVICE

Biomet Comprehensive Shoulder System

Total shoulder system designed to provide intraoperative flexibility for surgeons with unmatched humeral stem options, and infinite humeral head offset possibilities while meeting the growing demand for ease of glenoid preparation through a streamlined, low-profile, cannulated instrument platform

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Erin D Osborn · Zimmer Biomet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-24
Primary Completion
2026-02-28
Completion
2026-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03409718 on ClinicalTrials.gov